Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line

• Published in: PloS one 2016-08, Vol.11 (8), p.e0161803-e0161803
• Main Authors: Lutz, Norbert W, Banerjee, Pallavi, Wilson, Brian J, Ma, Jie, Cozzone, Patrick J, Frank, Markus H
• Format: Article
• Language: English
• Subjects: Acids; Alanine; Alanine - metabolism; Amino acids; Amino Acids - metabolism; ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism; Binding proteins; Biology and Life Sciences; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Breast cancer; Cell Line, Tumor; Cell Membrane - metabolism; Cell metabolism; Cell surface; Cellular Biology; Cold; Comparative analysis; Degradation products; Drug resistance; Energy; Energy metabolism; Gene expression; Gene Expression Regulation, Neoplastic; Genetic aspects; Glucose; Glucose - metabolism; Glycerylphosphorylcholine - metabolism; Glycolysis; Humans; Hypoxia; Inhibition; Interleukin 1; Lactates - metabolism; Lactic acid; Life Sciences; Lipid metabolism; Lipids; Lung cancer; Magnetic Resonance Spectroscopy; Melanoma; Melanoma - genetics; Melanoma - metabolism; Melanoma - pathology; Metabolism; Metabolites; Metabolomics; Metabolomics - methods; Monoclonal antibodies; Neoplastic Stem Cells - metabolism; NMR; NMR spectroscopy; Nuclear magnetic resonance; Phosphatidylethanolamines - metabolism; Phospholipids; Phospholipids - metabolism; Phosphorus; Physiological aspects; Pilot Projects; Research and Analysis Methods; RNA Interference; Spectroscopy; Spectrum analysis; Statistical analysis; Stem cells; Surface markers; Tumors; Water chemistry
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0161803

We present a pilot study aimed at determining the effects of expression of ATP-binding cassette member B5 (ABCB5), a previously described marker for melanoma-initiating cells, on cellular metabolism. Metabolic profiles for two groups of human G3361 melanoma cells were compared, i.e. wildtype melanoma cells with intact ABCB5 expression (ABCB5-WT) and corresponding melanoma cell variants with inhibited ABCB5 expression, through shRNA-mediated gene knockdown (ABCB5-KD). A comprehensive metabolomic analysis was performed by using proton and phosphorus NMR spectroscopy of cell extracts to examine water-soluble metabolites and lipids. Parametric and non-parametric statistical analysis of absolute and relative metabolite levels yielded significant differences for compounds involved in glucose, amino acid and phospholipid (PL) metabolism. By contrast, energy metabolism was virtually unaffected by ABCB5 expression. The sum of water-soluble metabolites per total protein was 17% higher in ABCB5-WT vs. ABCB5-KD G3361 variants, but no difference was found for the sum of PLs. Enhanced abundance was particularly pronounced for lactate (+ 23%) and alanine (+ 26%), suggesting an increase in glycolysis and potentially glutaminolysis. Increases in PL degradation products, glycerophosphocholine and glycerophosphoethanolamine (+ 85 and 123%, respectively), and redistributions within the PL pool suggested enhanced membrane PL turnover as a consequence of ABCB5 expression. The possibility of glycolysis modulation by an ABCB5-dependent IL1β-mediated mechanism was supported by functional studies employing monoclonal antibody (mAb)-dependent ABCB5 protein inhibition in wildtype G3361 melanoma cells. Our metabolomic results suggest that the underlying biochemical pathways may offer targets for melanoma therapy, potentially in combination with other treatment forms.